Shares in Elan Corp. fall on possible 5th case of disease linked to MS drug

DUBLIN, Ireland (AP) - Shares in Elan Corp. PLC fell Monday after a U.S. newspaper reported that its top drug in development, Tysabri, was being linked to a possible fifth case of a rare brain disease. Tysabri, which is being developed jointly with Biogen Idec Inc....More